Aristro Capital Markets Ltd.
You Are On :   Home  |  Equity  |   Company Profile  |  Board Meetings
 
Equity
Equity Analysis
Price
Volume
Analysis
News Analysis
Corporate Action
Other Market
Company Profile
Board Meetings
Bacil Pharma Ltd.
 
BSE Code 524516
ISIN Demat INE711D01018
Book Value (Rs.) 17.55
NSE Code NA
Dividend Yield  % 0.00
Market Cap  (Rs. Mn) 564.22
TTM PE (x) 36.28
TTM EPS (Rs.) 1.08
Face Value (Rs.) 10  
Source DateBoard Meeting DateDetails
11-May-2026 22-May-2026 Audited Results
05-Feb-2026 13-Feb-2026 Quarterly Results
06-Nov-2025 13-Nov-2025 Quarterly Results
02-Sep-2025 05-Sep-2025 Inter alia, To discuss and approve the following matters: ? Discussion on Notice for 38th Annual General Meeting for the Company. ? Discussion on Director Report of the Company for the Financial Year 2024-2025. ? Discussion to Fix Date, Place and Timing of 38th Annual General Meeting of the Company ? Discussion on matter related to Loan to Equity shares of the Company. ? Any other business with the permission of Chairperson.
19-Aug-2025 25-Aug-2025 Inter alia, to consider and approve:- 1. Discussion on Appointment of M/s Sarang Shivajirao Chavan& Associate as a Statutory Auditor of the Company; 2. Discussion on Appointment of New Director. 3. Any other business with the permission of Chairperson.
05-Aug-2025 12-Aug-2025 Quarterly Results
11-Jul-2025 16-Jul-2025 Inter alia, to consider and approve:- 1. To consider and discuss the appointment of a new Executive Director and Chief Financial Officer (CFO) of the Company; 2. To consider and discuss the resignation of the present Chief Financial Officer (CFO) of the Company. 3. Any other business with the permission of chair.
19-May-2025 26-May-2025 Audited Results
13-Jan-2025 21-Jan-2025 Quarterly Results
16-Oct-2024 23-Oct-2024 Quarterly Results
close X

Download Client Registration Documents

Client Registration Documents in Vernacular Languages

Member: NSE CAPITAL MARKET: INB231498438 | NSE FUTURE & OPTION: INF231498438 | BSE CAPITAL MARKET: INB011498434 | BSE FUTURE MARKET: INF011498434 | DP REGN No.:IN-DP-CDSL-704-2013 | Single SEBI Registration nos.: NSE & BSE: INZ000219238 | DP CDSL: IN-DP-407-2019
Attention Investor: Update your mobile number and email id with your stock broker.
Home| About Us | Services | Login | Research | Online Trading | Customer Support | Useful links | SEBI SCORE | Contact Us | Investor Charter | Share Links:  
Terms & Conditions |Disclaimer | Privacy Policy |Policy & Procedure | Feedback | Open An Account | Downloads |Customer Desk |Policy |Site Map |Segregation and Monitoring of Collateral
NSE | BSE | SEBI | NSDL | NCDEX | CDSL | MCX | NMCE | MCX-SX | RBI | Do & Don'ts | CDSL Circular | CDSL e-Voting | Rights & Obligations | Risk Disclousre Document
Details of Authorised Persons | Basic Details | SMART ODR | Policy on Handling of GTC Orders | Saral Account opening form | Rights and Obligation for DP
QR Code for DP | QR Code for Stock Broker | ARISTRO MGT7 | CSR Policy Aristro
Copyright Aristro Capital Markets Ltd. All Rights Reserved.
Designed, Developed & Content Powered By  Accord Fintech Pvt. Ltd.